Research & Development

FDA and CDC exploring unlikely relation between COVID-19 vaccine and stroke

The FDA and CDC have brought out new revelations that the revised COVID-19 injection from Pfizer Inc and its partner BioNTech could...

Delivering mRNA Into Extracellular Vesicles Decreases Wrinkles in Mice, Study Finds

Extracellular vesicles (EVs) have been found to be a viable alternative to lipid nanoparticles for the delivery of mRNA to mice's skin,...

Spiral Therapeutics completes $8.25M financing for phase 2 trial of hearing medication

Spiral Therapeutics has recently closed an $8.25 million financing round for the phase 2 research and development of SPT-2101, which is the...

Pfizer Steps Back From Early-Stage Rare Disease R&D

Pfizer is withdrawing from research and development for rare diseases in their initial phases. As part of a rethinking of its strategy...

CDC reports a new strain of omicron taking over the U.S.

CDC has warned of a new variant of omicron that has spread across the U.S. Concerns have been raised over the second...

Fentanyl’s dangerous effects potentially reversible by new compound

The devastation by fentanyl is reflected in the provisional statistics from the CDC (Centers for Disease Control and Prevention). According to the...

Study shows Apple AirPods can disrupt the market of OTC hearing aids

This year the FDA allowed the over-the-counter (OTC) sales of some hearing aids, due to which a lot of device developers have...

Zika antibody proves effective against infection

Less than a decade ago, Zika virus was causing panic across Central, Latin and South America. While the virus was less widespread...

Latest news

FDA and CDC exploring unlikely relation between COVID-19 vaccine and stroke

The FDA and CDC have brought out new revelations that the revised COVID-19 injection from Pfizer Inc...

Disappointing sales prompt AstraZeneca to pull out leukemia drug Lumoxiti from U.S. market

In a letter shared with healthcare providers, AstraZeneca has announced that it will be pulling its leukemia...

Sanofi’s Venture Capital units to receive over $750 million in investment to boost firm’s investment capabilities 

After a successful last year in which Sanofi Ventures made its second-highest number of deals, 10 rounds...

Must read

Surrounded by controversy, FDA approves Biogen’s Alzheimer’s drug Aduhelm

In the middle of the debate about the Alzheimer’s drug approval, the United States FDA has authorized Aduhelm

Amgen’s KRAS drug gets early FDA approval for lung cancer with specific mutation

On Friday, the United States FDA (Food and Drug Administration) has authorized a medication of Amgen Biopharmaceutical in patients with NSCLC

You might also likeRELATED
Recommended to you

Xeris Pharmaceuticals gets stockholder nod on Strongbridge Biopharma acquisition

The shareholders of Xeris Pharmaceuticals, on 15th...

Celltrion gets Canadian priority review for Covid-19 antibody treatment, Regdanvimab

Canadian biopharmaceutical company, Celltrion Healthcare Canada Ltd.,...